JPH0150209B2 - - Google Patents
Info
- Publication number
- JPH0150209B2 JPH0150209B2 JP58012324A JP1232483A JPH0150209B2 JP H0150209 B2 JPH0150209 B2 JP H0150209B2 JP 58012324 A JP58012324 A JP 58012324A JP 1232483 A JP1232483 A JP 1232483A JP H0150209 B2 JPH0150209 B2 JP H0150209B2
- Authority
- JP
- Japan
- Prior art keywords
- urokinase
- salts
- albumin
- dried
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 102000003990 Urokinase-type plasminogen activator Human genes 0.000 claims description 33
- 108090000435 Urokinase-type plasminogen activator Proteins 0.000 claims description 33
- 229960005356 urokinase Drugs 0.000 claims description 33
- -1 organic acid salts Chemical class 0.000 claims description 14
- 150000003839 salts Chemical class 0.000 claims description 9
- 238000002360 preparation method Methods 0.000 claims description 8
- 102000009027 Albumins Human genes 0.000 claims description 7
- 108010088751 Albumins Proteins 0.000 claims description 7
- 239000003381 stabilizer Substances 0.000 claims description 6
- 235000002639 sodium chloride Nutrition 0.000 description 24
- 102000008100 Human Serum Albumin Human genes 0.000 description 7
- 108091006905 Human Serum Albumin Proteins 0.000 description 7
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 7
- 238000000034 method Methods 0.000 description 5
- 239000011780 sodium chloride Substances 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000004108 freeze drying Methods 0.000 description 3
- 229910052736 halogen Inorganic materials 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 239000001509 sodium citrate Substances 0.000 description 3
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 3
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 235000011164 potassium chloride Nutrition 0.000 description 2
- 239000001103 potassium chloride Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 230000006641 stabilisation Effects 0.000 description 2
- 238000011105 stabilization Methods 0.000 description 2
- 230000000087 stabilizing effect Effects 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 150000007933 aliphatic carboxylic acids Chemical class 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 230000020764 fibrinolysis Effects 0.000 description 1
- 239000003527 fibrinolytic agent Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 229960002510 mandelic acid Drugs 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 238000011146 sterile filtration Methods 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP58012324A JPS59139323A (ja) | 1983-01-28 | 1983-01-28 | ウロキナ−ゼ乾燥製剤 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP58012324A JPS59139323A (ja) | 1983-01-28 | 1983-01-28 | ウロキナ−ゼ乾燥製剤 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS59139323A JPS59139323A (ja) | 1984-08-10 |
JPH0150209B2 true JPH0150209B2 (ko) | 1989-10-27 |
Family
ID=11802129
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP58012324A Granted JPS59139323A (ja) | 1983-01-28 | 1983-01-28 | ウロキナ−ゼ乾燥製剤 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS59139323A (ko) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61130223A (ja) * | 1984-11-28 | 1986-06-18 | Shionogi & Co Ltd | 抗菌性凍結乾燥製剤 |
JPS61238731A (ja) * | 1985-04-16 | 1986-10-24 | Green Cross Corp:The | ウロキナーゼ前駆体乾燥製剤 |
CA1336585C (en) * | 1985-04-16 | 1995-08-08 | Kazuo Morimoto | Method of stabilizing urokinase precursor and dry preparation containing said precursor |
NL8503097A (nl) * | 1985-11-11 | 1987-06-01 | Leuven Res & Dev Vzw | Geneesmiddel met thrombolytische werking. |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS54147916A (en) * | 1978-05-12 | 1979-11-19 | Sumitomo Chem Co Ltd | Preparation of urokinase injection |
-
1983
- 1983-01-28 JP JP58012324A patent/JPS59139323A/ja active Granted
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS54147916A (en) * | 1978-05-12 | 1979-11-19 | Sumitomo Chem Co Ltd | Preparation of urokinase injection |
Also Published As
Publication number | Publication date |
---|---|
JPS59139323A (ja) | 1984-08-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100491281B1 (ko) | 저당함량을가지는안정한알부민무함유재조합인자Vlll의제제 | |
US4965203A (en) | Purified thrombin preparations | |
JP4879104B2 (ja) | 高度に濃縮された、凍結乾燥された、および液体の、因子ix処方 | |
JP3530300B2 (ja) | 安定なトランスグルタミナーゼ製剤およびそれらを製造する方法 | |
JP2739050B2 (ja) | 抗血液凝固剤 | |
JPH0672105B2 (ja) | 血栓溶解剤及びその製法 | |
US4409233A (en) | Highly concentrated preparations of dopa compounds | |
US4244943A (en) | Method for preparing urokinase injection | |
HU202761B (en) | Process for producing stabilized erythropoietin compositions | |
US4837022A (en) | Composition containing tissue plasminogen activator | |
JPS6235756B2 (ko) | ||
JPH0150209B2 (ko) | ||
KR950010321B1 (ko) | 인간 트롬빈 제제의 가열처리방법 | |
KR940003056B1 (ko) | 우로키나제 전구체를 안정화시키는 방법 | |
US5366730A (en) | Stabilized compositions having human tissue type plasminogen activator enzymatic activity | |
US6051223A (en) | Method of improving solubility of tissue plasminogen activator | |
CA1289472C (en) | Tpa-containing medical composition | |
JPS6051119A (ja) | ウロキナ−ゼ乾燥製剤 | |
EP1254944B1 (en) | Dry compositions containing hydrophobic amino acid | |
JP2971680B2 (ja) | 組織プラスミノーゲン活性化因子含有組成物 | |
JP2739584B2 (ja) | ウロキナーゼ型プラスミノーゲンアクチベーター乾燥製剤 | |
CA2046598C (en) | T-pa solubilisation | |
JPS6112675B2 (ko) | ||
JPH0597703A (ja) | 改変型組織プラスミノーゲン活性化因子含有組成物 | |
KR20130128658A (ko) | 데옥시콜린산 또는 그의 염을 포함하는 조성물 및 효소의 안정화 방법 |